Poly(ADP-Ribose) Polymerase 1 Promotes Oxidative-Stress-Induced Liver Cell Death via Suppressing Farnesoid X Receptor α

REFERENCES

• Kassam A, Miao B, Young PR, Mukherjee R. 2003. Retinoid X receptor (RXR) agonist-induced antagonism of farnesoid X receptor (FXR) activity due to absence of coactivator recruitment and decreased DNA binding. J. Biol. Chem. 278:10028–10032.
   PubMed Web of Science ®Google Scholar
• Lee FY, Lee H, Hubbert ML, Edwards PA, Zhang Y. 2006. FXR, a multipurpose nuclear receptor. Trends Biochem. Sci. 31:572–580.
   PubMed Web of Science ®Google Scholar
• Otte K, Kranz H, Kober I, Thompson P, Hoefer M, Haubold B, Remmel B, Voss H, Kaiser C, Albers M, Cheruvallath Z, Jackson D, Casari G, Koegl M, Paabo S, Mous J, Kremoser C, Deuschle U. 2003. Identification of farnesoid X receptor beta as a novel mammalian nuclear receptor sensing lanosterol. Mol. Cell. Biol. 23:864–872.
   PubMed Web of Science ®Google Scholar
• Seol W, Choi HS, Moore DD. 1995. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol. Endocrinol. 9:72–85.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Edwards PA. 2008. FXR signaling in metabolic disease. FEBS Lett. 582:10–18.
   PubMed Web of Science ®Google Scholar
• Meng Z, Wang Y, Wang L, Jin W, Liu N, Pan H, Liu L, Wagman L, Forman BM, Huang W. 2010. FXR regulates liver repair after CCl4-induced toxic injury. Mol. Endocrinol. 24:886–897.
   PubMedGoogle Scholar
• Chen WD, Wang YD, Zhang L, Shiah S, Wang M, Yang F, Yu D, Forman BM, Huang W. 2010. Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription. Hepatology 51:953–962.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang YD, Chen WD, Wang X, Lou G, Liu N, Lin M, Forman BM, Huang W. 2012. Promotion of liver regeneration/repair by farnesoid X receptor in both liver and intestine in mice. Hepatology 56:2336–2343.
   PubMedGoogle Scholar
• D'Amours D, Desnoyers S, D'Silva I, Poirier GG. 1999. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem. J. 342(Part 2):249–268.
   PubMedGoogle Scholar
• Virag L, Szabo C. 2002. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 54:375–429.
   PubMed Web of Science ®Google Scholar
• Kim MY, Zhang T, Kraus WL. 2005. Poly(ADP-ribosyl)ation by PARP-1: ‘PAR-laying' NAD+ into a nuclear signal. Genes Dev. 19:1951–1967.
   PubMed Web of Science ®Google Scholar
• Kraus WL. 2008. Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation. Curr. Opin. Cell Biol. 20:294–302.
   PubMed Web of Science ®Google Scholar
• Woodhouse BC, Dianov GL. 2008. Poly ADP-ribose polymerase-1: an international molecule of mystery. DNA Repair (Amst.) 7:1077–1086.
   PubMed Web of Science ®Google Scholar
• Conner GE, Salathe M, Forteza R. 2002. Lactoperoxidase and hydrogen peroxide metabolism in the airway. Am. J. Respir. Crit. Care Med. 166:S57–S61.
   PubMed Web of Science ®Google Scholar
• Mangerich A, Burkle A. 2012. Pleiotropic cellular functions of PARP1 in longevity and aging: genome maintenance meets inflammation. Oxid. Med. Cell. Longev. 2012:321653. doi:10.1155/2012/321653.
   PubMed Web of Science ®Google Scholar
• National Research Council Committee on the Care and Use of Laboratory Animals, Institute of Laboratory Animal Resources, and Commission on Life Sciences. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
   Google Scholar
• Neufeld DS. 1997. Isolation of rat liver hepatocytes. Methods Mol. Biol. 75:145–151.
   PubMedGoogle Scholar
• Huang D, Wang Y, Yang C, Liao Y, Huang K. 2009. Angiotensin II promotes poly(ADP-ribosyl)ation of c-Jun/c-Fos in cardiac fibroblasts. J. Mol. Cell. Cardiol. 46:25–32.
   PubMedGoogle Scholar
• Huang D, Yang C, Wang Y, Liao Y, Huang K. 2009. PARP-1 suppresses adiponectin expression through poly(ADP-ribosyl)ation of PPARγ in cardiac fibroblasts. Cardiovasc. Res. 81:98–107.
   PubMedGoogle Scholar
• Mathews MT, Berk BC. 2008. PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2. Arterioscler. Thromb. Vasc. Biol. 28:711–717.
   PubMed Web of Science ®Google Scholar
• Simonin F, Menissier-de Murcia J, Poch O, Muller S, Gradwohl G, Molinete M, Penning C, Keith G, de Murcia G. 1990. Expression and site-directed mutagenesis of the catalytic domain of human poly(ADP-ribose)polymerase in Escherichia coli. Lysine 893 is critical for activity. J. Biol. Chem. 265:19249–19256.
   PubMed Web of Science ®Google Scholar
• Schmiesing JA, Ball ARJr, Gregson HC, Alderton JM, Zhou S, Yokomori K. 1998. Identification of two distinct human SMC protein complexes involved in mitotic chromosome dynamics. Proc. Natl. Acad. Sci. U. S. A. 95:12906–12911.
   PubMedGoogle Scholar
• Xu W, Cho H, Evans RM. 2003. Acetylation and methylation in nuclear receptor gene activation. Methods Enzymol. 364:205–223.
   PubMedGoogle Scholar
• Gibson GE, Zhang H, Xu H, Park LC, Jeitner TM. 2002. Oxidative stress increases internal calcium stores and reduces a key mitochondrial enzyme. Biochim. Biophys. Acta 1586:177–189.
   PubMed Web of Science ®Google Scholar
• Wang YD, Yang F, Chen WD, Huang X, Lai L, Forman BM, Huang W. 2008. Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo. Mol. Endocrinol. 22:1622–1632.
   PubMedGoogle Scholar
• Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S, Fallon K, Woods C, Boulares AH. 2007. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-κB nuclear translocation, and foam cell death. Circulation 115:2442–2450.
   PubMed Web of Science ®Google Scholar
• Cavone L, Chiarugi A. 2012. Targeting poly(ADP-ribose) polymerase-1 as a promising approach for immunomodulation in multiple sclerosis? Trends Mol. Med. 18:92–100.
   PubMedGoogle Scholar
• Koh SH, Park Y, Song CW, Kim JG, Kim K, Kim J, Kim MH, Lee SR, Kim DW, Yu HJ, Chang DI, Hwang SJ, Kim SH. 2004. The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals. Eur. J. Neurosci. 20:1461–1472.
   PubMedGoogle Scholar
• Butler AJ, Ordahl CP. 1999. Poly(ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription. Mol. Cell Biol. 19:296–306.
   PubMed Web of Science ®Google Scholar
• Cohen-Armon M, Visochek L, Rozensal D, Kalal A, Geistrikh I, Klein R, Bendetz-Nezer S, Yao Z, Seger R. 2007. DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation. Mol. Cell 25:297–308.
   PubMed Web of Science ®Google Scholar
• Modica S, Gadaleta RM, Moschetta A. 2010. Deciphering the nuclear bile acid receptor FXR paradigm. Nucl. Recept. Signal. 8:e005. doi:10.1621/nrs.08005.
   PubMedGoogle Scholar
• Frankenberg T, Miloh T, Chen FY, Ananthanarayanan M, Sun AQ, Balasubramaniyan N, Arias I, Setchell KD, Suchy FJ, Shneider BL. 2008. The membrane protein ATPase class I type 8B member 1 signals through protein kinase Cζ to activate the farnesoid X receptor. Hepatology 48:1896–1905.
   PubMedGoogle Scholar
• Kemper JK, Xiao Z, Ponugoti B, Miao J, Fang S, Kanamaluru D, Tsang S, Wu SY, Chiang CM, Veenstra TD. 2009. FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab. 10:392–404.
   PubMed Web of Science ®Google Scholar
• Kemper JK. 2011. Regulation of FXR transcriptional activity in health and disease: emerging roles of FXR cofactors and post-translational modifications. Biochim. Biophys. Acta 1812:842–850.
   PubMed Web of Science ®Google Scholar
• Hollman DA, Milona A, van Erpecum KJ, van Mil SW. 2012. Anti-inflammatory and metabolic actions of FXR: insights into molecular mechanisms. Biochim. Biophys. Acta 1821:1443–1452.
   PubMed Web of Science ®Google Scholar